From: Prognosis of liver abscess with no identified organism
CNLA (n = 156) | CPLA (n = 246) | Causative organisms | P value | ||||
---|---|---|---|---|---|---|---|
E.coli (n = 74) | K.pneumoniae (n = 133) | P value* | Other (n = 39) | ||||
Age, years, median (IQR) | 61 (12) | 66 (8) | 66.5 (14.3) | 66 (18) | 0.95 | 66 (7) | 0.02 |
Sex, male, n(%) | 113 (72.4%) | 156 (63.4%) | 49 (66.2%) | 79 (59.4%) | 0.33 | 28 (71.8%) | 0.06 |
Comorbidity | |||||||
Diabetes mellitus | 35 (22.4%) | 74 (30.1%) | 24 (33.8%) | 35 (26.3%) | 0.26 | 14 (35.9%) | 0.12 |
Hypertension | 63 (40.4%) | 89 (36.2%) | 26 (35.1%) | 48 (36.1%) | 0.89 | 15 (38.5%) | 0.39 |
Cholelithiasis and biliary tract disease | 6 (3.8%) | 35 (14.2%) | 18 (24.3%) | 11 (8.3%) | 0.001 | 6 (15.4%) | 0.001 |
Liver disease | 12 (7.7%) | 33 (13.4%) | 18 (24.3%) | 10 (7.5%) | 0.001 | 5 (12.8%) | 0.07 |
Chronic kidney disease | 3 (1.9%) | 5 (2.0%) | 1 (1.4%) | 3 (2.3%) | 0.65 | 1 (2.6%) | 0.94 |
Malignancy | 24 (15.4%) | 54 (22.0%) | 27 (36.5%) | 11 (8.3%) | 0.0001 | 16 (41.0%) | 0.10 |
Transplant | 2 (1.3%) | 2 (0.8%) | 1 (1.4%) | 1 (0.8%) | 0.67 | 0 (0%) | 0.64 |
Presentation as a sepsis | 5 (3.2%) | 7 (2.8%) | 1 (1.4%) | 6 (4.5%) | 0.23 | 0 (0%) | 0.84 |
ICU admission | 22 (14.1%) | 36 (14.6%) | 11 (14.9%) | 20 (15.0%) | 0.97 | 5 (12.8%) | 0.88 |
Bacteremia | – | 99 (40.2%) | 21 (28.4%) | 56 (42.1%) | 0.05 | 22 (56.4%) | – |
ESBL production | – | 23 (31.1%) | 3 (2.3%) | 0.0001 |